Skip to main content

Andrew Berchuck, MD

Andrew Berchuck, MD
James M. Ingram Professor of Gynecologic Oncology
Campus Mail: 25171 Morris Bldg, Durham, NC 27710
Phone: (919) 684-3765
Email: berch001@mc.duke.edu

Dr. Andrew Berchuck is Director of the Duke Division of Gynecologic Oncology and holds the James M. Ingram Distinguished Professorship. He is a practicing oncologist who is actively involved in the surgical and chemotherapy management of women with ovarian, endometrial and lower genital tract cancers. This includes minimally invasive laparoscopic surgical approaches. He also has developed a research program that focuses on the molecular-genetic alterations involved in malignant transformation of the ovarian and endometrial epithelium. He has published over 300 peer-reviewed papers in these areas. The objectives of his research include 1) identification of ovarian cancer susceptibility polymorphisms through a population-based case-control molecular epidemiologic study, and 2) use of genomic approaches  to elucidate the molecular heterogenetity of ovarian cancer. Thirty fellows and residents have worked in his lab, several of whom are now funded investigators. His research efforts have been recognized nationally and he has received awards for best oral presentation at the annual meetings of both the Society of Gynecologic Oncology and the International Gynecologic Cancer Society. Dr. Berchuck was awarded the Barbara Thomason Ovarian Cancer Research Professorship by the American Cancer Society in 2006. He has served as editor of several books in the field including Principles and Practice of Gynecologic Oncology. Dr. Berchuck also has a major commitment to national activities, and was President of the Society of Gynecologic Oncology in 2008. He served as chair of the scientific advisory committee of the Ovarian Cancer Research Fund (http://www.ocrf.org) in New York City. Finally, he is also head of the steering committee of the international Ovarian Cancer Association Consortium (OCAC), a group of 50 case-control studies that are working together to identify ovarian cancer susceptibility polymorphisms (www.srl.cam.ac.uk/consortia/ocac/index.html).

Education and Training

  • M.D., Case Western Reserve University, 1980

Research

Dr Berchuck is interested in the molecular pathogenesis of ovarian and endometrial cancer. 

View Publications

Publications

Lu, KH, Berchuck, A, and Kauff, ND. "Hereditary gynecologic cancers." In Principles and Practice of Gynecologic Oncology: Sixth Edition, 60-69. May 8, 2013.

Scholars@Duke

Berchuck, A, Levine, DA, Farley, JH, and Birrer, MJ. "Molecular pathogenesis of gynecologic cancers." In Principles and Practice of Gynecologic Oncology: Sixth Edition, 30-59. May 8, 2013.

Scholars@Duke

Barakat, RR, Berchuck, A, Markman, M, and Randall, ME. "Preface." Principles and Practice of Gynecologic Oncology: Sixth Edition (May 8, 2013): xi-xii.

Scholars@Duke

Barakat, RR, Berchuck, A, Markman, M, and Randall, ME. Principles and practice of gynecologic oncology: Sixth edition. May 8, 2013.

Scholars@Duke

White, KL, Vierkant, RA, Fogarty, ZC, Charbonneau, B, Block, MS, Pharoah, PDP, Chenevix-Trench, G, for AOCS/ACS group,, , Rossing, MA, Cramer, DW, Pearce, CL, Schildkraut, JM, Menon, U, Kjaer, SK, Levine, DA, Gronwald, J, Culver, HA, Whittemore, AS, Karlan, BY, Lambrechts, D, Wentzensen, N, Kupryjanczyk, J, Chang-Claude, J, Bandera, EV, Hogdall, E, Heitz, F, Kaye, SB, Fasching, PA, Campbell, I, Goodman, MT, Pejovic, T, Bean, Y, Lurie, G, Eccles, D, Hein, A, Beckmann, MW, Ekici, AB, Paul, J, Brown, R, Flanagan, JM, Harter, P, du Bois, A, Schwaab, I, Hogdall, CK, Lundvall, L, Olson, SH, Orlow, I, Paddock, LE, Rudolph, A, Eilber, U, Dansonka-Mieszkowska, A, Rzepecka, IK, Ziolkowska-Seta, I, Brinton, L, Yang, H, Garcia-Closas, M, Despierre, E, Lambrechts, S, Vergote, I, Walsh, C, Lester, J, Sieh, W, McGuire, V, Rothstein, JH, Ziogas, A, Lubinski, J, Cybulski, C, Menkiszak, J, Jensen, A, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Berchuck, A, Wu, AH, Pike, MC, Van Denberg, D, Terry, KL, Vitonis, AF, Doherty, JA, Johnatty, SE, Defazio, A, Song, H, Tyrer, J, Sellers, TA, Phelan, CM, Kalli, KR, Cunningham, JM, Fridley, BL, and Goode, EL. "Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 22, no. 5 (May 2013): 987-992.

Full Text

Pearce, CL, Rossing, MA, Lee, AW, Ness, RB, Webb, PM, for Australian Cancer Study (Ovarian Cancer), , Australian Ovarian Cancer Study Group, , Chenevix-Trench, G, Jordan, SM, Stram, DA, Chang-Claude, J, Hein, R, Nickels, S, Lurie, G, Thompson, PJ, Carney, ME, Goodman, MT, Moysich, K, Hogdall, E, Jensen, A, Goode, EL, Fridley, BL, Cunningham, JM, Vierkant, RA, Weber, RP, Ziogas, A, Anton-Culver, H, Gayther, SA, Gentry-Maharaj, A, Menon, U, Ramus, SJ, Brinton, L, Wentzensen, N, Lissowska, J, Garcia-Closas, M, Massuger, LFAG, Kiemeney, LALM, Van Altena, AM, Aben, KKH, Berchuck, A, Doherty, JA, Iversen, E, McGuire, V, Moorman, PG, Pharoah, P, Pike, MC, Risch, H, Sieh, W, Stram, DO, Terry, KL, Whittemore, A, Wu, AH, Schildkraut, JM, Kjaer, SK, and Ovarian Cancer Association Consortium, . "Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 22, no. 5 (May 2013): 880-890.

Full Text

Cancer Genome Atlas Research Network, , Kandoth, C, Schultz, N, Cherniack, AD, Akbani, R, Liu, Y, Shen, H, Robertson, AG, Pashtan, I, Shen, R, Benz, CC, Yau, C, Laird, PW, Ding, L, Zhang, W, Mills, GB, Kucherlapati, R, Mardis, ER, and Levine, DA. "Integrated genomic characterization of endometrial carcinoma." Nature 497, no. 7447 (May 2013): 67-73.

Full Text

Amankwah, EK, Tyrer, J, Lin, H-Y, Tsai, Y-Y, Chen, Z, Han, G, Qu, X, Goode, E, Cunninghan, J, Iverson, E, Ramus, S, Berchuck, A, Schildkraut, J, Monteiro, A, Gayther, S, Narod, S, Pharoah, P, Sellers, TA, and Phelan, C. "Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry." April 15, 2013.

Full Text

Siamakpour- Reihani, S, Jiang, C, Turner, T, Owzar, K, Berchuck, A, Dewhirst, M, and Alvarez Secord, A. "Abstract 330A: Differential expression of angiogenic genes in invasive high grade serous ovarian carcinomas." April 15, 2013.

Full Text

Park, J, Huang, Z, Berchuck, A, and Murphy, S. "Abstract 4767: Preclinical mouse model of recurrent epithelial ovarian cancer." April 15, 2013.

Full Text

Pages